Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
暂无分享,去创建一个
G. Canonica | P. Chanez | R. Louis | B. Cosío | A. Burden | T. Harrison | E. Garcia Gil | J. Zangrilli | N. Lugogo | F. Menzella | A. Mohan | L. McDermott